Diese Website ist nur für medizinisches Fachpersonal. Zu unserer Patientenwebsite gelangen Sie hier
FreeStyle Libre 3 – the #1 CGM worldwide
Smaller than the size of two stacked 5-cent Euro coins, easy to wear6 with a discreet6 sensor for up to 14 days.
Patients simply scan to activate the sensor – no finger pricking or code entry is required.
The sensor is easy to apply6 using a one-piece applicator. It requires no in-person training to use.6
The sensor can be worn while patients shower, swim and exercise.7
The sensor sends glucose readings directly to patients’ smartphones2 every minute to provide complete glycaemic profiles**, so you can make informed treatment decisions.
38% reduction in time spent in hypoglycaemia without increasing A1c10
40% reduction in nocturnal hypoglycaemia10
50% reduction in serious hypoglycaemia (≤3.0 mmol/L)10
The fully customisable glucose alarms allow users to set high and low glucose alarm thresholds, based on individual needs and preferences. Alarms let patients know the minute they’ve crossed the preset thresholds, allowing them to take action to manage their glucose levels.
Three optional sound/vibration alarms alert patients to:
As the most accurate 14-day continuous glucose monitoring system13, FreeStyle Libre 3 empowers patients to act faster to avoid hypoglycaemia. It can help reduce time spent in hypoglycaemia10,14 and improve overall glucose control for patients.11,15 Find out more about the accuracy and reliability of the FreeStyle Libre 3 system.
95% of patients have a better understanding of their glucose fluctuations12
1hr more Time in Range per
day compared to finger
pricking10
0.55% reduction of A1c at at
2-4 months and sustained at
month 12 in adults and
children with T1D and adults
with T2D.11
NOTE: statistically significant A1c reduction based on the confidence interval range.
Studies data collected with FreeStyle Libre system and are applicable to the FreeStyle Libre 3 system based on technological similarities.
Easy to apply using a one-piece applicator
Easy to wear with a discreet sensor
Easy to share results1
Easy to monitor glucose remotely
Quickly assess your patient’s Time In Ranges in a single-page, comprehensive report
Provides further details, treatment, and personalised medication considerations to help you manage your patient’s diabetes
A quick overview of your patient’s daily insulin usage to help make treatment adjustments
References
1. Data on file, Abbott Diabetes Care, Inc. Based on the number of users worldwide for the FreeStyle Libre portfolio compared to the number of users for
other leading personal use sensor-based glucose monitoring systems.
2. The FreeStyle Libre 3 app is only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Sharing of glucose data requires registration with LibreView.
3. Based on signal range in Dexcom G6 CGM User Guide and Medtronic Guardian Connect System User Guide.
4. Hilliard, M., et al. Diabetes Technology & Therapeutics. (2019): https:/doi.org/10.1089/dia.2019.0142
5. Among patient-applied sensors.
6. Data on file, Abbott Diabetes Care, Inc.
7. Sensor is water-resistant up to 1 metre (3 feet) of water. Do not immerse longer than 30 minutes.
8. Dexcom G6 CGM User Guide and Medtronic Guardian Connect System User Guide.
9. Notifications will only be received when alarms are turned on and the sensor is within 10 meters unobstructed of the reading device.
10. Bolinder, J. et al. Lancet (2016): http://doi.org/10.1016/S0140-6736(16)31535-5.
11. Evans, M. et al. Diabetes Ther (2020): https://doi.org/10.1007/s13300-019-00720-0.
12. Fokkert, M. et al. BMJ Open Diab Res Care (2019): https://doi.org/10.1136/bmjdrc-2019-000809.
13. Alva, S. et al. Diabetes Ther. (2023); doi: 10.1007/s13300-023-01385-6.
14. Haak, T. et al. Diabetes Ther. (2017): https://doi.org/10.1007/s13300-016-0223-6.
15. Yaron, M. et al. Diabetes Care (2019): https://doi.org/10.2337/dc18-0166.
16. The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose device data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
** Unger, J. et al, Postgrad Med. (2020): https://doi.org/10.1080/00325481.2020.1744393.
Der untenstehende Button "Ja" leitet Sie auf andere Websites als die von Abbott Laboratories weiter. Links, die zu anderen Websites führen, stehen nicht unter der Kontrolle von Abbott Laboratories, und Abbott Laboratories ist nicht verantwortlich für den Inhalt einer solchen Website oder eines auf einer solchen Website enthaltenen Links. Abbott Laboratories stellt Ihnen diese Links nur als Service zur Verfügung, und die Aufnahme eines Links bedeutet nicht, dass Abbott Laboratories die betreffende Website befürwortet.
Provider.FreeStyle.Abbott/de-de/ ist eine Website mit Produktinformationen und nur für in Deutschland ansässige und praktizierende Angehörige der Gesundheitsberufe bestimmt.
Wenn Sie in einem anderen Land ansässig sind, wenden Sie sich bitte an Ihren örtlichen Abbott-Vertreter, um die korrekten Informationen über die in Ihrem Land erhältlichen Produkte zu erhalten.
.svg){kind=logo}
